Luis Bahamonde

Prof. Dr. Luis Bahamonde


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2022 in Cureus
Verified
Journal Article
Open access
PEPablo Escudero-Acurio
Pablo Escudero-Acurio
FMFrancisco Mahaluf
Francisco Mahaluf
LBLuis Bahamonde
Luis Bahamonde
Pelvic chondrosarcomas are a major clinical challenge since the only therapeutic approach available is surgical resection. Reconstruction after partial resection of the pelvis including the acetabulum or the hip joint is a laborious and rigorous surgical procedure. Numerous complications are associated with different reparative methods. Moreover, due to the anatomical complexities of the area, adequate surgical margins are difficult to achieve in many cases, which are closely related to the advent of local recurrence of the tumor. Several techniques for hip function restoration and skeletal reconstruction have been reported. The purpose of this report is to describe a novel pelvic reconstruction technique for PI-II resection that required a custom-designed implant. We present the case of a 61-year-old female patient with chronic pain in the gluteal region. The pelvis’s magnetic resonance imaging (MRI) showed an osteolytic tumor in the right iliac wing that compromises the acetabular roof. The diagnosis was a grade 2 central chondrosarcoma. Surgery included the reconstruction of the acetabulum by inserting two Schanz pins coated with hydroxyapatite, one in the iliopubic corridor and the other in the ischium. A supporting “pyramid” was built, unitizing both Schanz with cement, onto which an acetabular cage was inserted. The procedure was completed with a conventional total hip prosthesis. The patient presented an acute prosthesis infection, which positively responded to prompt surgical lavage and antibiotic treatment. After 10 months of follow-up, the patient remains free of infection, with weight-bearing as tolerated, without pain, and with excellent hip motion. No tumor recurrence has occurred. Medialization of the construct has occurred as expected, with no evidence of implant loosening. The technique used in this patient is novel, could be considered cost-effective, and has allowed the reconstruction of a functional hip. For resections of the acetabular area and preservation of the ischium and pelvic zones, this technique may be an acceptable option.

1 October 2025 in OTA International
Verified
Journal Article
Open access
AZAlvaro Zamorano
Alvaro Zamorano
MVMatías A. Vaccia
Matías A. Vaccia
RPRodrigo Ignacio Parra
Rodrigo Ignacio Parra
TTTomas Turner
Tomas Turner
IRIgnacio Rivera
Ignacio Rivera
LBLuis Bahamonde
Luis Bahamonde
Introduction: Gustilo–Anderson type IIIB open tibial fractures carry a high risk of fracture-related infection (FRI) due to extensive soft tissue damage and frequent delays in coverage. Although early orthoplastic intervention lowers infection rates, many trauma centers lack the resources for same-day or early flap coverage. This study aimed to assess the relationship between timing of flap coverage and FRI risk in a young, healthy population, and to define a clinically relevant therapeutic window. Materials and Methods: A retrospective cohort study was conducted at a single Level I trauma center (2012–2023). Patients with GA IIIB tibial fractures were treated under a standardized protocol with strict inclusion criteria. Timing of flap coverage was analyzed using Levene test, Student t test, and ROC curve analysis with the Youden index to determine the optimal infection-risk threshold. Results: Out of 332 open tibial fractures, 41 patients with GA IIIB injuries met inclusion criteria. Mean time to coverage was 24.6 days. FRI occurred in 15 patients (36.6%). Delayed coverage was significantly associated with FRI ( P < 0.001). ROC analysis showed an AUC of 0.83; the Youden index identified <12 days as the optimal cutoff (100% sensitivity, 34.6% specificity). None of the 10 patients treated within 12 days developed FRI, versus 56.6% in those treated later ( P < 0.05). Conclusions: Coverage within 12 days minimizes infection risk in GA IIIB tibial fractures. Although immediate coverage remains ideal, a defined 12-day window offers practical guidance, especially where early orthoplastic care is not feasible.

9 September 2020
Verified
Book Chapter
Open access
PDF file
LBLuis Bahamonde
Luis Bahamonde
AZAlvaro Zamorano
Alvaro Zamorano
PZPierluca Zecchetto
Pierluca Zecchetto
Operative treatment of tibial fractures located at the proximal metaphyseal-epiphyseal and distal metaphyseal-epiphyseal areas, including those with articular extensions, is a technical challenge. Common methods for surgical management include plates (locking and nonlocking), external fixation devices, and intramedullary nails. All these methods have shown satisfactory results in terms of quality of reduction and clinical and radiological outcomes. The authors present some technical methods and strategies that have been useful for the surgical approach, reduction, and fixation of these lesions with the use of locked nails.

1 January 2023 in Annals of Joint
Verified
Journal Article
Open access
PDF file
LBLuis Bahamonde
Luis Bahamonde
PZPierluca Zecchetto
Pierluca Zecchetto
Original Article Resection and reconstruction of the proximal femur with revision stems: a cost-effective alternative Luis Bahamonde, Pierluca Zecchetto

22 May 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
AZAlvaro Zamorano
Alvaro Zamorano
MVMatías A. Vaccia
Matías A. Vaccia
CACarlos Felipe Albarrán
Carlos Felipe Albarrán
RPRodrigo Ignacio Parra
Rodrigo Ignacio Parra
TTTomas Turner
Tomas Turner
LBLuis Bahamonde
Luis Bahamonde
Introduction: Open tibial fractures carry a high risk of fracture-related infection (FRI), and prevention typically relies on early antibiotics and debridement. However, achieving optimum local antibiotic concentration remains challenging. Gentamicin-coated intramedullary nails (GCN) have been developed to prevent biofilm formation, showing short-term efficacy without interfering with fracture healing. Medium- and long-term data on GCN use are limited. This study aimed to assess the effectiveness and safety of GCN in medium-term follow-up. Methods: A prospective cohort study of patients with open tibial fractures was treated with GCN under a standardized protocol, with a minimum follow-up of 24 months. Patients with traumatic amputations, protocol infringement, or loss of follow-up were excluded. The analysis assessed overall FRI incidence by Gustilo–Anderson (GA) classification. Results: Of 907 patients, 139 were included, with 2 lost to follow-up. The overall FRI incidence was 8.8%, the average healing time was 34.3 weeks, and the non-union rate was 2.2%. FRI incidence by GA classification was 0% in GA I, 2.9% in GA II, 2.9% in GA IIIA, 44.4% in GA IIIB, and 33.3% in GA IIIC. External fixation (EF) was required in 45.2% of cases, with 16.1% developing FRI (14.3% in GA II, 2.8% in GA IIIA, 50% in GA IIIB, and 33.3% in GA IIIC). In non-EF cases, FRI occurred in 2.7% of patients (2.9% in GA IIIA and 25% in GA IIIB). No adverse effects were reported due to locally administered gentamicin. Conclusions: In the medium term, GCN has consistently demonstrated safety and efficacy in preventing FRI in open tibial fractures, particularly in GA IIIA cases, even with the use of temporary EF. These findings highlight its potential as a valuable tool in managing open tibial fractures. However, further studies with long-term outcomes are needed to evaluate its effectiveness in GA IIIB and IIIC fractures.

29 May 2024
Verified
Book Chapter
Open access
PDF file
LBLuis Bahamonde
Luis Bahamonde
AZAlvaro Zamorano
Alvaro Zamorano
Operative treatment of distal femoral fractures has evolved significantly in tems of strategy and implants available for fracture fixation. Major advances include improvements in fixation devices, as well as the understanding of the pathomechanics of fixation failures. As the complexity of the fracture increases, and in conjunction with considerations of the general status and functionality of the patient, judicious planning, surgical approach and choice of implants can be undertaken, in order to obtain optimal functional restoration. This goes along tightly with the capability of a given construct to withstand deforming forces, while early mobilization and weight bearing take splace, and ultimately bone healing occurs. Minimizing the risk of complications, such as hardware failure and nonunion, depend closely on proper planning and execution. Factors inherent to the patient and the fracture itself are beyond the surgeon’s control. But taking these in mind, allows the surgeon to select properly the timing, surgical approach and choice of implant—or combination of implants—, best suited for a given patient.